Hemifacial atrophy progressive
Hemifacial Atrophy Progressive, also known as Parry-Romberg Syndrome, is a rare disorder characterized by the slow and progressive atrophy of the skin and soft tissues on one side of the face. The condition is not fully understood and its cause remains largely unknown, though it is thought to involve autoimmune mechanisms.
Symptoms and Diagnosis[edit | edit source]
The onset of Hemifacial Atrophy Progressive typically occurs in childhood or early adolescence, but it can start at any age. The condition manifests as a unilateral atrophy affecting the skin, subcutaneous tissue, muscles, and sometimes bone. This leads to a noticeable asymmetry in the face. In some cases, the atrophy can also affect the tongue, soft palate, and the mucous membranes of the mouth. Symptoms may include changes in skin pigmentation, hair loss in the affected area, and dental abnormalities due to the involvement of the underlying bone.
Diagnosis is primarily clinical, based on the characteristic appearance of the affected individual. Imaging studies, such as MRI or CT scans, can be used to assess the extent of the atrophy and involvement of deeper structures. There is no specific test for Hemifacial Atrophy Progressive, and diagnosis often involves ruling out other conditions that can cause similar facial asymmetry.
Treatment[edit | edit source]
There is no cure for Hemifacial Atrophy Progressive, and treatment focuses on managing symptoms and improving cosmetic appearance. Surgical interventions, such as fat grafting, dermal fillers, or reconstructive surgery, may be considered to restore facial symmetry. Orthodontic treatment or dental implants may be necessary for those with dental abnormalities. In cases where the condition affects the eye or eyelid, ophthalmologic surgery may be required to protect vision.
Physical therapy and exercises may be recommended to maintain muscle function and prevent contractures in the affected side of the face. Additionally, psychological support is important for individuals with Hemifacial Atrophy Progressive, as the condition can have a significant impact on self-esteem and emotional well-being.
Epidemiology and Prognosis[edit | edit source]
Hemifacial Atrophy Progressive is a rare condition, and its exact prevalence is unknown. It appears to affect females slightly more often than males and has no known geographical, racial, or ethnic predilections. The progression of atrophy typically slows down or stops after several years, but the cosmetic and functional effects can be permanent.
See Also[edit | edit source]
Hemifacial atrophy progressive Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD